Earnings Call Summary | Zapata Computing(ZPTA.US) Q1 2024 Earnings Conference
Earnings Call Summary | Zapata Computing(ZPTA.US) Q1 2024 Earnings Conference
The following is a summary of the Zapata Computing Holdings Inc. (ZPTA) Q1 2024 Earnings Call Transcript:
以下是扎帕塔計算機控股公司（ZPTA）2024年第一季度業績電話會議記錄摘要：
Financial Performance:
財務業績：
Zapata Computing Holdings reported Q1 2024 revenues of $1.22 million, a decrease from $1.5 million in Q1 2023 due to the completion of certain customer contracts.
Gross margin remained flat at 14%, and operating costs were $5.24 million versus $5.3 million in Q1 2023.
The company reported a GAAP operating loss of $5.08 million and a GAAP net loss of $22.32 million.
They raised a total of $6.1 million through financing activities in Q1 2024 and additional capital post-Q1 2024.
Zapata Computing Holdings報告稱，由於某些客戶合同的完成，2024年第一季度收入爲122萬美元，低於2023年第一季度的150萬美元。
毛利率持平至14％，運營成本爲524萬美元，而2023年第一季度爲530萬美元。
該公司報告的GAAP營業虧損爲508萬美元，GAAP淨虧損爲2,232萬美元。
他們在2024年第一季度通過融資活動和2024年第一季度後的額外資本共籌集了610萬美元。
Business Progress:
業務進展：
Zapata formed strategic partnerships with Tech Mahindra, One Stop Systems, and D-Wave and continued their collaboration with Insilico Medicine, University of Toronto, and Harvard University.
They created viable cancer drug candidates using quantum-enhanced generative AI and continued to innovate in creating tools for predicting hazardous conditions in racing.
Ongoing discussions are taking place with potential customers in diverse sectors, indicating promising growth in their pipeline.
The company is enhancing its team and IP portfolio and has demonstrated significant operational successes, notably in environments like IndyCar racing and network intrusion detection for carriers.
Zapata與Tech Mahindra、One Stop Systems和D-Wave建立了戰略合作伙伴關係，並繼續與英硅醫學、多倫多大學和哈佛大學合作。
他們使用量子增強的生成人工智能創造了可行的抗癌候選藥物，並在創建預測賽車危險條件的工具方面繼續進行創新。
正在與不同領域的潛在客戶進行持續的討論，這表明他們的產品線有望增長。
該公司正在加強其團隊和知識產權組合，並取得了顯著的運營成功，尤其是在印地賽車和運營商網絡入侵檢測等環境中。
Tips: For more comprehensive details, please refer to the IR website. The article is only for investors' reference without any guidance or recommendation suggestions.
提示：欲了解更多詳情，請訪問投資者關係網站。本文僅供投資者參考，不構成任何投資建議。
譯文內容由第三人軟體翻譯。